Miltenyi Biotec Inc entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 9999900, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.
To acquire more information, please contact by calling (858) 202-1850 during business hours. You can also write to the business’ Single Location at 6125 Cornerstone Court East # 100, San Diego, California CA 92121. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Miltenyi Biotec Inc |
| Place of Business: | 6125 Cornerstone Court East # 100, San Diego, CA 92121 |
| Contact Number: | (858) 202-1850 |
| Type of Service: | Commercial Biotechnical Research |
| SIC Number: | 8731 |
| NAICS Number: | 9999900 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2013 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Miltenyi Biotec Inc is a company operating from San Diego, California providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 9999900 as Commercial Biotechnical Research.
With a current employee count of 1 to 4, Miltenyi Biotec Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative at (858) 202-1850 for related queries, or to locate its Single Location using the coordinates 32.89642,-117.18839.
The Single Location can also be found at the street address 6125 Cornerstone Court East # 100 in San Diego, California 92121 and can be engaged online through the company website at , the company Twitter , and Facebook page .